Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

CELZ Creative Medical Technology Holdings Inc

4,385

-0,0104 (-0,24%)

08 Jun 2024 - Geschlossen

Verzögert um 15 Minuten

Form PRE 14A - Other preliminary proxy statements

null

Creative Medical Technol... (NASDAQ:CELZ)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Creative Medical Technol... Charts.

Creative Medical Technol... (NASDAQ:CELZ)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Creative Medical Technol... Charts.

News Creative Medical Technology Holdings Inc

Form DEF 14A - Other definitive proxy statements
Mittwoch 5 Juni 2024 (3 Tage vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 17 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Freitag 10 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Creative Medical Technology Holdings Provides Corporate Update
Mittwoch 27 März 2024 (2 Monate vor) • Business Wire

Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access
Donnerstag 7 März 2024 (3 Monate vor) • Business Wire

Biotech Finds Mid-Week Success Following FDA Announcement
Mittwoch 6 März 2024 (3 Monate vor) • AllPennyStocks.com

Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy
Mittwoch 6 März 2024 (3 Monate vor) • Business Wire

Form 8-K - Current report
Mittwoch 20 Dezember 2023 (6 Monate vor) • Edgar (US Regulatory)

Creative Medical Technology Holdings Provides Corporate Update
Mittwoch 15 November 2023 (7 Monate vor) • PR Newswire (US)

Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain
Dienstag 10 Oktober 2023 (8 Monate vor) • PR Newswire (US)

Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain
Dienstag 19 September 2023 (9 Monate vor) • PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Freitag 11 August 2023 (10 Monate vor) • Edgar (US Regulatory)

Weitere Creative Medical Technology Holdings Inc News-Artikel

Euro vs US Dollar

Deutsche Telekom (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen